Amgen Inc.
Processes for Preparing a MDM2 Inhibitor
Last updated:
Abstract:
The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsu- lfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3- yl)acetic acid as well as intermediates thereof.
Status:
Application
Type:
Utility
Filling date:
30 Aug 2019
Issue date:
11 Nov 2021